Highbridge Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-82,300
Closed -$1.01M 1406
2016
Q2
$1.01M Sell
82,300
-95,700
-54% -$721K 0.02% 616
2016
Q1
$1.2M Buy
+178,000
New +$1.14M 0.02% 672

Other funds holding EXAS

Highbridge Capital Management's EXAS Position: Q1 2026 in Review

Highbridge Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 480,733 shares — an estimated $48.8M sold.

Highbridge Capital Management first reported a position in EXAS in Q3 2016 and held it in 3 quarters. The position peaked at $48.8M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Highbridge Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Highbridge Capital Management sold 480,733 Exact Sciences shares in Q1 2026, an estimated $48.8M.
  • Highbridge Capital Management first reported a position in Exact Sciences in Q3 2016 and held it in 3 quarters.
  • Highbridge Capital Management's Exact Sciences position peaked at $48.8M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Highbridge Capital Management's 13F filing for Q1 2026, filed 15 May 2026.